Latest filing published 22 May 2025 for Ginkgo Bioworks Holdings, Inc..
No signal scores available.
Mark E. Dmytruk discloses dealings in Ginkgo Bioworks Holdings, Inc. to SEC (Form 4). Over a trading history stretching from 30 September 2022 to 21 May 2025, the count stands at 140 filings.
No open-market purchase appears, only 36 sales worth €3.4M. Outside the open market, there are 103 option exercises. 2025 to date brings no purchases and 5 sales.
On 22 May 2025 came the latest disclosure, an option exercise in Ginkgo Bioworks Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 38 declarations